- Home
- MCI vs HUMA Comparison
MCI vs HUMA Comparison
Compare MCI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCI
- HUMA
- Stock Information
- Founded
- MCI 1971
- HUMA 2004
- Country
- MCI United States
- HUMA United States
- Employees
- MCI N/A
- HUMA N/A
- Industry
- MCI Trusts Except Educational Religious and Charitable
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- MCI Finance
- HUMA Health Care
- Exchange
- MCI Nasdaq
- HUMA Nasdaq
- Market Cap
- MCI N/A
- HUMA 221.8M
- IPO Year
- MCI N/A
- HUMA N/A
- Fundamental
- Price
- MCI $19.92
- HUMA $1.21
- Analyst Decision
- MCI
- HUMA Strong Buy
- Analyst Count
- MCI 0
- HUMA 6
- Target Price
- MCI N/A
- HUMA $14.60
- AVG Volume (30 Days)
- MCI 40.4K
- HUMA 2.9M
- Earning Date
- MCI 01-01-0001
- HUMA 05-20-2025
- Dividend Yield
- MCI 8.46%
- HUMA N/A
- EPS Growth
- MCI N/A
- HUMA N/A
- EPS
- MCI 1.82
- HUMA N/A
- Revenue
- MCI N/A
- HUMA N/A
- Revenue This Year
- MCI N/A
- HUMA N/A
- Revenue Next Year
- MCI N/A
- HUMA $1,178.20
- P/E Ratio
- MCI $9.88
- HUMA N/A
- Revenue Growth
- MCI N/A
- HUMA N/A
- 52 Week Low
- MCI $12.96
- HUMA $1.15
- 52 Week High
- MCI $19.24
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- MCI 36.86
- HUMA 30.35
- Support Level
- MCI $20.20
- HUMA $1.35
- Resistance Level
- MCI $20.98
- HUMA $1.48
- Average True Range (ATR)
- MCI 0.49
- HUMA 0.10
- MACD
- MCI -0.09
- HUMA 0.03
- Stochastic Oscillator
- MCI 8.87
- HUMA 4.26
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.